Biggest News Aggregation in the World
📰 Cornell Scale News

Cornell Scale News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cornell Scale. Real-time updates on events, politics, business and more.

Axsome Therapeutics, Inc. Announces AXS-05 Achieves Primary Endpoint in the ACCORD Phase 3 Trial in Alzheimer’s Disease Agitation

Axsome Therapeutics, Inc. announced that AXS-05, a novel, oral, investigational NMDA receptor antagonist with multimodal activity, met the primary and key secondary endpoints in the ACCORD Phase 3... | November 29, 2022
Alzheimer Disease Cooperative Study Axsome Therapeutics Inc Drug Administration Axsome Therapeutics Assessing Clinical Outcomes Disease Agitation

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science